The Role of Maternal Gestational Diabetes in Inducing Fetal Endothelial Dysfunction

Journal of Cellular Physiology

Volumn 230, Issue 11, 2015, Pages 2695-2705

  Sultan, Samar A ^a   Liu, Wanting ^b   Peng, Yonghong ^b   Roberts, W ^b   Whitelaw, Donald ^c   Graham, Anne M ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DICHLORODIHYDROFLUORESCEIN DIACETATE; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; NITROBLUE TETRAZOLIUM; PROTEIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR 165B; VASCULOTROPIN; ISOPROTEIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS DISEASE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLAMMATION; INSULIN TREATMENT; MATERNAL DIABETES MELLITUS; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; MTT ASSAY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; BIOSYNTHESIS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; UMBILICAL VEIN;

CELL PROLIFERATION; DIABETES, GESTATIONAL; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GLUCOSE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PREGNANCY; PROTEIN ISOFORMS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84937893114     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24993     Document Type: Article

References (52)

1. Adya R, Tan BK, Punn A, Chen J, Randeva HS. 2008. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: Novel insights into visfatin-induced angiogenesis. Cardiovasc Res 78:356.
2. Alexa A, Rahnenfuhrer J, Lengauer T. 2006. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22:1600-1607.
3. Anastasiou E, Lekakis JP, Alevizaki M, Papamichael CM, Megas J, Souvatzoglou A, Stamatelopoulos SF. 1998. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21:2111.
4. Arikan S, Konukoğlu D, Arikan C, Akçay T, Davas I. 2001. Lipid peroxidation and antioxidant status in maternal and cord blood. Gynecol Obstet Invest 51:145-149.
5. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ. 2002. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62:4123.
6. Bates DO, Mavrou A, Qiu Y, Carter JG, Hamdollah-Zadeh M, Barratt S, Gammons MV, Millar AB, Salmon AHJ, Oltean S, Harper SJ. 2013. Detection of VEGF-Axxxb isoforms in human tissues. PLoS ONE 8:e68399.
7. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhusl W. 1995. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44:1323-1327.
8. Biri A, Onan A, Devrim E, Babacan F, Kavutcu M, Durak I. 2006. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 27:327-332.
9. Brownlee M 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820.
10. Ceriello A, Esposito K, Ihnat M, Thorpe J, Giugliano D. 2009. Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. J Clin Endocrinol Metab 94:2751.
11. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. 2008. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57:1349-1354.
12. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561.
13. Cui TG, Foster RR, Saleem M, Mathieson PW, Gillatt DA, Bates DO, Harper SJ. 2004. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein. Am J Physiol-Renal Physiol 286:F767-F773.
14. Da Wei Huang BTS, Lempicki RA. 2008. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
15. Dabbagh AJ, Frei B. 1995. Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems. J Clin Invest 96:1958.
16. Davignon J, Ganz P. 2004. Role of endothelial dysfunction in atherosclerosis. Circulation 109:27.
17. Eccles KA, Sowden H, Porter KE, Parkin SM, Homer-Vanniasinkam S, Graham AM. 2008. Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. Atherosclerosis 200:69-79.
18. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. 2008. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205:2409.
19. Eligini S, Barbieri SS, Cavalca V, Camera M, Brambilla M, De Franceschi M, Tremoli E, Colli S. 2005. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor alpha and phorbol ester in human endothelial cells. Cardiovasc Res 65:683-693.
20. Epstein FH, Ross R. 1999. Atherosclerosis -an inflammatory disease. N Engl J Med 340:115-126.
21. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhusl W, Wagner OF. 1996. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4313-4317.
22. Giri H, Chandel S, Dwarakanath LS, Sreekumar S, Dixit M. 2013. Increased endothelial inflammation, sTie-2 and arginase activity in umbilical cords obtained from gestational mothers. PLoS ONE 8:1-9.
23. Grossmann S, Bauer S, Robinson P, Vingron M. 2006. An improved statistic for detecting over-represented gene ontology annotations in gene sets. Springer 3909: 85-98.
24. Hagberg C E, Mehlem A, Falkevall A, Muhl L, Fam B C, Ortsater H, Scotney P, Nyqvist D, Samen E, Lu L, Stone-Elander S, Proietto J, Andrikopoulos S, Sjoholm A, Nash A, Eriksson U. 2012. Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature 490:426-430.
25. Huang BTS, Lempicki RA. 2008. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
26. Ido Y, Carling D, Ruderman N. 2002. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells. Diabetes 51:159.
27. Ihnat MA, Thorpe JE, Kamat CD, Szab C, Green DE, Warnke LA, Lacza Z, Cseleny k, Shakir K. 2007. Reactive oxygen species mediate a cellular 'memory'of high glucose stress signalling. Diabetologia 50:1523-1531.
28. Jay D, Hitomi H, Griendling KK. 2006. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40:183-192.
29. Kalyanaraman B, Darley-Usmar V, Davies KJA, Dennery PA. 2012. Measuring reactive oxygen and nitrogen species with fluorescent probes: Challenges and limitations. Free Radic Biol Med 52:1-6.
30. Kamal K, Du W, Mills I, Sumpio BE. 1998. Antiproliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem 71:491-501.
31. Keaney JF, Jr, Frei B. 1994. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. Frei E Natural antioxidants in human health and disease 1:303-351.
32. Kwok CF, Goldstein BJ, Muller-Wieland D, Lee TS, Kahn CR, King GL. 1989. Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats. J Clin Invest 83:127.
33. Li X, Kumar A, Zhang F, Lee C, Tang Z. 2012. Complicated life, complicated VEGF-B. Trends Mol Med 18:119-127.
34. Mulvihill NT, Foley B, Crean P, Walsh M. 2002. Prediction of cardiovascular risk using soluble cell adhesion molecules. Eur Heart J 23:1569.
35. Mordwinkin NM, Ouzounian J G, Yedigarova L, Montoro MN, Louie SG, Rodgers KE. 2013. Alteration of endothelial function markers in women with gestational diabetes and their fetuses. J MAtern Fetavl Neonatal Med 26:507-512.
36. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. 2005. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The N Engl J Med 353:2643.
37. Niu XF, Smith CW, Kubes P. 1994. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74:1133-1140.
38. Onozaki A, Midorikawa S, Sanada H, Hayashi Y, Baba T, Katoh T, Watanabe T. 2004. Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: Inhibitory effects of thiazolidinedione. Biochem Biophys Res Commun 317:24-29.
39. Panel IC 2010. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676-682.
40. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, Runge MS. 1999. Stimulation of a Vascular Smooth Muscle Cell NAD (P) H Oxidase by Thrombin EVIDENCE THAT p47 phox MAY PARTICIPATE IN FORMING THIS OXIDASE IN VITRO AND IN VIVO. J Biol Chem 274:19814-19822.
41. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36.
42. Robinson CJ, Stringer SE. 2001. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114:853.
43. Sauer H, Wartenberg M, Hescheler J. 2001. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem: international journal of experimental cellular physiology, biochemistry, and pharmacology 11:173.
44. Sciolo MG, Bielli A, Agostinelli S, Tarquini C, Arcuri G, Ferlosio A, Costanza G, Doldo E, Orlandi A. 2014. Antioxidant treatment prevents serum deprivation and TNFalpha induced endothelial dysfunction through the inhibition of NADPH oxidase 4 and the restoration of beta oxidation. J Vasc Res 51:327-337.
45. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD. 1994. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979.
46. Suhail M, Patil S, Khan S, Siddiqui S. 2010. Antioxidant vitamins and lipoperoxidation in non pregnant, pregnant and gestational diabetic women: Erythrocytes osmotic fragility profiles. J CLin MEd Res 2:266.
47. Takanashi T, Ogura Y, Taguchi H, Hashizoe M, Honda Y. 1997. Fluorophotometric quantitation of oxidative stress in the retina in vivo. Invest Ophthal Vis Sci 38:2721.
48. West IC 2001. Radicals and oxidative stress in diabetes. Diabet Med 17:171-180.
49. West NA, Crume TL, Maligie MA, Dabelea D. 2012. Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia 54:504-507.
50. Yang Z, Mo X, Gong Q, Pan Q, Yang X, Cai W, Li C, Ma J X, He Y, Gao G. 2008. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose. Apoptosis 13:1331-1343.
51. Zeng H, Dvorak HF, Mukhopadhyay D. 2001. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem 276:26969.
52. Zhang LS, Ma HW, Greyner HJ, Zuo W, Mummert ME. 2010. Inhibition of cell proliferation by CD44: Akt is inactivated and EGR 1 is down regulated. Cell Prolif 43:385-395.